Betta Pharmaceuticals Co., Ltd.

Betta Pharmaceuticals Co., Ltd. company information, Employees & Contact Information

Betta Pharmaceuticals Co., Ltd. (SZ300558), established in 2003 in Hangzhou, China, is one of the leading Chinese pharmaceutical companies dedicated to develop and commercialize innovative oncology products to meet high unmet medical needs. With over 1,300 employees in Hangzhou and Beijing, China, Betta’s development capabilities range from small molecule and biologics discovery, clinical development, registration, manufacturing, sales and marketing. Betta’s leading product – icotinib (Conmana®), the first innovative oncology product developed and commercially launched by a Chinese pharmaceutical company – is the No.1-selling targeted therapy treating non-small cell lung cancer patients carrying EGFR mutations in China, having achieved 1.25 billion RMB annual sales in 2018. Betta currently has three programs under late-stage clinical development, three programs under proof-of-concept clinical development, two programs under IND review by the NMPA and close to twenty programs under pre-clinical development. Betta has set up joint ventures with Amgen Inc. (AMGN) and Tyrogenex Inc. and is the majority shareholder of Xcovery LLC. For additional information, please visit http://en.bettapharma.com.

Company Details

Employees
22
Address
355 Xingzhong Rd., Hangzhou,zhejiang 311100,china
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Hangzhou, Zhejiang
Looking for a particular Betta Pharmaceuticals Co., Ltd. employee's phone or email?

Betta Pharmaceuticals Co., Ltd. Questions

News

EyePoint Pharmaceuticals Announces Expanded License Agreement with Betta Pharmaceuticals for EYP-1901 in China, Hong Kong, Macau and Taiwan - EyePoint Pharmaceuticals

EyePoint Pharmaceuticals Announces Expanded License Agreement with Betta Pharmaceuticals for EYP-1901 in China, Hong Kong, Macau and Taiwan EyePoint Pharmaceuticals

Betta Pharma eyes Hong Kong listing - GlobalCapital

Betta Pharma eyes Hong Kong listing GlobalCapital

Betta Pharma Gets Nod to Trial Cancer Drug in Tandem With Immunotherapy Medicine - 一财全球Yicai Global

Betta Pharma Gets Nod to Trial Cancer Drug in Tandem With Immunotherapy Medicine 一财全球Yicai Global

C4 Therapeutics and Betta Pharmaceuticals Announce - GlobeNewswire

C4 Therapeutics and Betta Pharmaceuticals Announce GlobeNewswire

Top Betta Pharmaceuticals Co., Ltd. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant